Analysts Stocks

      Make Sense of Stock Market Analyst News

      Analysts Stocks

          AnaChart has built the world’s largest dataset of public analyst price targets and one of the largest datasets of analyst ratings, helping investors identify the top analysts for each stock, track how opinions change over time, and know when their signals matter.

          Advance Package 7 Day Free Trial Video Demo
          • Get the most extensive information on stock market analysts
          • Get real-time email alerts on new analyst calls — with full track records and performance stats
          • Compare all experts opinions on each stock under one chart
          • See Stock Market Sentiment towards your stock in High Resolution

          AnaChart scours through the media for you, crunches millions of numbers, and shows you the track record of every single analyst’s price targets and ratings so you can make a better informed decision on stock sentiment news in real time.

          Get started

          949K

          Price targets and ratings

          5,617

          Covered stocks on NYSE and NASDAQ

          20

          Years of analysts’ activity records processed.

          4,074

          Wall Street analysts

          Top daily price target moves

          New Stock Forecast

          Last update - 25-Feb-2026 (3PM) EST

          #

          Analyst

          The Stock

          Rating

          Price Target Change

          Average Days to Hit Target

          Potential Upside Change

          Price Target Met Ratio

          1
          Glen Santangelo
          GLEN SANTANGELO(BARCLAYS)

          HIMS(Hims Hers Health)

          Buy
          $48->$25
          $23 (47.92%)
          360
          $43.4->$20.4
          943.48%->443.48%
          2/2 (100%)
          2
          Craig Hettenbach
          CRAIG HETTENBACH(MORGAN STANLEY)

          HIMS(Hims Hers Health)

          Hold
          $40->$21
          $19 (47.5%)
          $35.4->$16.4
          769.57%->356.52%
          3
          Youssef Squali

          ODD(ODDITY Tech Ltd. Ordinary Shares)

          Hold
          $80->$18
          $62 (77.5%)
          468
          $50.98->$11.02
          175.67%->37.97%
          6/7 (85.71%)
          4
          Brad Erickson

          GDDY(Godaddy)

          Buy
          $200->$100
          $100 (50%)
          83
          $107.7->$7.7
          116.68%->8.34%
          8/11 (72.73%)
          5
          Ryan Tomasello

          OPAD(Offerpad Solutions)

          Hold
          $1.75->$1
          $0.75 (42.86%)
          67
          $0.97->$0.22
          124.36%->28.21%
          6/8 (75%)
          6
          Ashish Sabadra

          CLVT(CLARIVATE PLC)

          Hold
          $5->$3
          $2 (40%)
          97
          $2.65->$0.65
          112.77%->27.66%
          3/16 (18.75%)
          7
          Julian Harrison

          AKBA(Akebia Ther)

          Buy
          $5->$4
          $1 (20%)
          602
          $3.76->$2.76
          303.23%->222.58%
          1/3 (33.33%)
          8
          David Larsen

          EVH(Evolent Health)

          Buy
          $10->$8
          $2 (20%)
          397
          $7.44->$5.44
          290.63%->212.5%
          12/19 (63.16%)
          9
          Jason Celino
          JASON CELINO(KEYBANK)

          WDAY(Workday)

          Buy
          $260->$155
          $105 (40.38%)
          173
          $122.19->$17.19
          88.67%->12.47%
          1/8 (12.5%)
          10
          Andres Sheppard
          ANDRES SHEPPARD(CANTOR FITZGERALD)

          LCID(Lucid Group)

          Hold
          $21->$14
          $7 (33.33%)
          57
          $11.08->$4.08
          111.69%->41.13%
          12/27 (44.44%)

          Check TSLA, AMZN, BABA, MRNA, PFE and AAPL with full access for free without registration

          Learn how to take advantage of stock analysts' price target charts for better research

          When you see analysts or inside traders who prove themselves repeatedly, you will know whom to pay attention to and when to act

          ✖

          What is AnaChart?